Tuberculosis: a problem with persistence
Top Cited Papers
- 1 November 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 1 (2) , 97-105
- https://doi.org/10.1038/nrmicro749
Abstract
Mycobacterium tuberculosis is one of most successful pathogens of mankind, infecting one-third of the global population and claiming two million lives every year. The ability of the bacteria to persist in the form of a long-term asymptomatic infection, referred to as latent tuberculosis, is central to the biology of the disease. The persistence of bacteria in superficially normal tissue was recognized soon after the discovery of the tubercle bacillus, and much of our knowledge about persistent populations of M. tuberculosis dates back to the first half of the last century. Recent advances in microbial genetics and host immunity provide an opportunity for renewed investigation of this persistent threat to human health.Keywords
This publication has 88 references indexed in Scilit:
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Analysis of the dormancy-induciblenarK2promoter inMycobacterium bovisBCGFEMS Microbiology Letters, 2000
- Up-regulation ofnarX, encoding a putative ‘fused nitrate reductase’ in anaerobic dormantMycobacterium bovisBCGFEMS Microbiology Letters, 1999
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- The Epidemiology of Tuberculosis in San Francisco -- A Population-Based Study Using Conventional and Molecular MethodsNew England Journal of Medicine, 1994
- A guinea pig model of experimental airborne tuberculosis for evaluation of the response to chemotherapy: the effect on bacilli in the initial phase of treatmentTubercle, 1991
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989
- The variability of mycobacterium tuberculosis in patients with cavitary pulmonary tuberculosis in the course of chemotherapyTubercle, 1987
- THE TREATED PULMONARY LESION AND ITS TUBERCLE BACILLUS.*The Lancet Healthy Longevity, 1956
- Über die granuläre, nach Ziehl nicht färbbare Form des TuberkulosevirusLung, 1907